If you don't know history, then you don't know anything. You are a leaf that doesn't know it is part of a tree. " - Michael Crichton
Today, we look at a small 'Busted IPO' focusing on metabolic disorders.
Company Overview:
Allena Pharmaceuticals (ALNA) is a Newton, Massachusetts based biopharmaceutical company that IPO'd late in 2017. The company's focus is on developing oral enzyme therapeutics to treat individuals with rare and severe metabolic disorders that affect the kidneys. The metabolic disorders in focus are those that result in excessive accumulation of particular